Simbiosys
Chicago, US · Founded 2018 · Delaware corporation · 3 known investors
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
Founders & leadership
Simbiosys was founded in 2018 by John A Cole, Joe Peterson, John Cole, and Tushar Pandey.
JA
John A ColeCo-founder
JP
Joe PetersonCo-founder
JC
John ColeCo-founder
TP
Tushar PandeyCo-founder
JP
Joseph PetersonExecutive
SS
Stacey StevensExecutive
Board
VC
LC
Lucy CoassinBoard director
RA
Ronnie AndrewsBoard director
WH
Investors · 3
Reported raises · per SEC filings
Form D private placements$6.1M disclosed across 2 rounds · 2018–2024
▶$5.2MraisedJan 2025 · 13 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lucy CoassinDirector
- Vikram ChaudheryDirector
- Ronnie AndrewsDirector
- William HyunDirector
- Joseph PetersonExecutive Officer, Director
- Stacey StevensExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $5.2M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · 3 investors · BiotechnologyRule 506(b)
▶$900KraisedNov 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John A ColeExecutive Officer
- Joseph R PetersonExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $900K
- Minimum investment
- $50K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Simbiosys do?
- SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
- Who founded Simbiosys?
- Simbiosys was founded by John A Cole, Joe Peterson, John Cole, Tushar Pandey in 2018.
- Who are Simbiosys's investors?
- Simbiosys's investors include AV8 Ventures, Genoa Ventures, GENERAL INCEPTION.
- How much funding has Simbiosys raised?
- Simbiosys has disclosed $6.1M raised across 2 rounds.
- Where is Simbiosys headquartered?
- Simbiosys is headquartered in Chicago, US.